Chopas James George 4
4 · Apellis Pharmaceuticals, Inc. · Filed Mar 18, 2025
Insider Transaction Report
Form 4
Chopas James George
VP/Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-03-17$24.82/sh−183$4,543→ 47,955 total
Footnotes (1)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on March 14, 2025